|
2019 Journal Article Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter studyDrago, Joshua Z., Lawrence, Donald, Livingstone, Elisabeth, Zimmer, Lisa, Chen, Tianqi, Giobbie-Hurder, Anita, Amann, Valerie C., Mangana, Joanna, Siano, Marco, Zippelius, Alfred, Dummer, Reinhard, Goldinger, Simone M. and Sullivan, Ryan J. (2019). Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter study. Melanoma Research, 29 (1), 65-69. doi: 10.1097/CMR.0000000000000527 |
|
2019 Journal Article Peripheral blood TCR repertoire profiling may facilitate patient stratification for immunotherapy against melanomaHogan, Sabrina A., Courtier, Anais, Cheng, Phil F., Jaberg-Bentele, Nicoletta F., Goldinger, Simone M., Manuel, Manuarii, Perez, Solene, Plantier, Nadia, Mouret, Jean-Francois, Thi Dan Linh Nguyen-Kim,, Raaijmakers, Marieke I. G., Kvistborg, Pia, Pasqual, Nicolas, Haanen, John B. A. G., Dummer, Reinhard and Levesque, Mitchell P. (2019). Peripheral blood TCR repertoire profiling may facilitate patient stratification for immunotherapy against melanoma. Cancer Immunology Research, 7 (1), 77-85. doi: 10.1158/2326-6066.CIR-18-0136 |
|
2018 Journal Article Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infectionTio, Martin, Rai, Rajat, Ezeoke, Ogochukwu M., McQuade, Jennifer L., Zimmer, Lisa, Khoo, Chloe, Park, John J., Spain, Lavinia, Turajlic, Samra, Ardolino, Luke, Yip, Desmond, Goldinger, Simone M., Cohen, Justine V., Millward, Michael, Atkinson, Victoria, Kane, Alisa Y., Ascierto, Paolo A., Garbe, Claus, Gutzmer, Ralf, Johnson, Douglas B., Rizvi, Hira A., Joshua, Anthony M., Hellmann, Matthew D., Long, Georgina V. and Menzies, Alexander M. (2018). Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection. European Journal of Cancer, 104, 137-144. doi: 10.1016/j.ejca.2018.09.017 |
|
2018 Journal Article The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the GlobeDimitriou, Florentia, Krattinger, Regina, Ramelyte, Egle, Barysch, Marjam J., Micaletto, Sara, Dummer, Reinhard and Goldinger, Simone M. (2018). The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe. Current Oncology Reports, 20 (11) 87. doi: 10.1007/s11912-018-0732-8 |
|
2018 Journal Article Phase I, open-label study of pasireotide in patients with <i>BRAF</i>-wild type and <i>NRAS</i>-wild type, unresectable and/or metastatic melanomaDummer, Reinhard, Michielin, Olivier, Nageli, Mirjam Chantal, Goldinger, Simone M., Campigotto, Federico, Kriemler-Krahn, Ulrike, Schmid, Herbert, Pedroncelli, Alberto, Micaletto, Sara and Schadendorf, Dirk (2018). Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanoma. Esmo Open, 3 (5) UNSP e000388. doi: 10.1136/esmoopen-2018-000388 |
|
2018 Journal Article Sarcoid-like reactions in patients receiving modern melanoma treatmentDimitriou, Florentia, Frauchiger, Anna L., Urosevic-Maiwald, Mirjana, Naegeli, Mirjam C., Goldinger, Simone M., Barysch, Marjam, Franzen, Daniel, Kamarachev, Jivko, Braun, Ralph, Dummer, Reinhard and Mangana, Joanna (2018). Sarcoid-like reactions in patients receiving modern melanoma treatment. Melanoma Research, 28 (3), 230-236. doi: 10.1097/CMR.0000000000000437 |
|
2018 Conference Publication The utility of chemotherapy after immunotherapy failure in metastatic melanoma: A multicenter case seriesGoldinger, Simone M., Lo, Serigne, Hassel, Jessica Cecile, Forschner, Andrea, McKean, Meredith Ann, Zimmer, Lisa, Khoo, Chloe Chia Hoey, Dummer, Reinhard, Eroglu, Zeynep, Buchbinder, Elizabeth Iannotti, Ascierto, Paolo Antonio, Gutzmer, Ralf, Rozeman, Elisa A., Hoeller, Christoph, Johnson, Douglas Buckner, Gesierich, Anja, Kolblinger, Peter, Benannoune, Naima, Cohen, Justine Vanessa and Menzies, Alexander M. (2018). The utility of chemotherapy after immunotherapy failure in metastatic melanoma: A multicenter case series. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2018.36.15_suppl.e21588 |
|
2018 Journal Article Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study (vol 91, pg 116, 2018)Valpione, Sara, Carlino, Matteo S., Mangana, Johanna, Mooradian, Meghan J., McArthur, Grant, Schadendorf, Dirk, Hauschild, Axel, Menzies, Alexander M., Arance, Ana, Ascierto, Paolo A., Di Giacomo, AnnaMaria, de Rosa, Francesco, Larkin, James, Park, John J., Goldinger, Simone M., Sullivan, Ryan J., Xu, Wen, Livingstone, Elisabeth, Weichenthal, Michael, Rai, Rajat, Gaba, Lydia, Long, Georgina V. and Lorigan, Paul (2018). Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study (vol 91, pg 116, 2018). European Journal of Cancer, 93, 158-158. doi: 10.1016/j.ejca.2018.02.001 |
|
2018 Journal Article Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patientsHecht, Markus, Meier, Friedegund, Zimmer, Lisa, Polat, Bulent, Loquai, Carmen, Weishaupt, Carsten, Forschner, Andrea, Gutzmer, Ralf, Utikal, Jochen S., Goldinger, Simone M., Geier, Michael, Hassel, Jessica C., Balermpas, Panagiotis, Kiecker, Felix, Rauschenberg, Ricarda, Dietrich, Ursula, Clemens, Patrick, Berking, Carola, Grabenbauer, Gerhard, Schadendorf, Dirk, Grabbe, Stephan, Schuler, Gerold, Fietkau, Rainer, Distel, Luitpold V. and Heinzerling, Lucie (2018). Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients. British Journal of Cancer, 118 (6), 785-792. doi: 10.1038/bjc.2017.489 |
|
2018 Journal Article Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective studyValpione, Sara, Carlino, Matteo S., Mangana, Johanna, Mooradian, Meghan J., McArthur, Grant, Schadendorf, Dirk, Hauschild, Axel, Menzies, Alexander M., Arance, Ana, Ascierto, Paolo A., Di Giacomo, AnnaMaria, de Rosa, Francesco, Larkin, James, Park, John J., Goldinger, Simone M., Sullivan, Ryan J., Xu, Wen, Livingstone, Elisabeth, Weichenthal, Michael, Rai, Rajat, Gaba, Lydia, Long, Georgina V. and Lorigan, Paul (2018). Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study. European Journal of Cancer, 91, 116-124. doi: 10.1016/j.ejca.2017.12.007 |
|
2018 Journal Article A Longitudinal Analysis of IDO and PDL1 Expression during Immune- or Targeted Therapy in Advanced MelanomaKrahenbuhl, Lukas, Goldinger, Simone M., Mangana, Joanna, Kerl, Katrin, Chevolet, Ines, Brochez, Lieve, Horak, Christine, Levesque, Mitch, Dummer, Reinhard and Cheng, Phil F. (2018). A Longitudinal Analysis of IDO and PDL1 Expression during Immune- or Targeted Therapy in Advanced Melanoma. Neoplasia, 20 (2), 218-225. doi: 10.1016/j.neo.2017.12.002 |
|
2017 Journal Article Successful retreatment with combined BRAF/MEK inhibition in metastatic BRAFV600-mutated melanomaAmann, V. C., Hoffmann, D., Mangana, J., Dummer, R. and Goldinger, S. M. (2017). Successful retreatment with combined BRAF/MEK inhibition in metastatic BRAFV600-mutated melanoma. Journal of the European Academy of Dermatology and Venereology, 31 (10), 1638-1640. doi: 10.1111/jdv.14268 |
|
2017 Journal Article Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumabBrueggemann, C., Kirchberger, M. C., Goldinger, S. M., Weide, B., Konrad, A., Erdmann, M., Schadendorf, D., Croner, R. S., Krahenbuhl, L., Kaehler, K. C., Hafner, C., Leisgang, W., Kiesewetter, F., Dummer, R., Schuler, G., Stuerzl, M. and Heinzerling, L. (2017). Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab. Journal of Cancer Research and Clinical Oncology, 143 (10), 1977-1984. doi: 10.1007/s00432-017-2450-2 |
|
2017 Journal Article Electrical Impedance Spectroscopy in Skin Cancer DiagnosisBraun, Ralph P., Mangana, Johanna, Goldinger, Simone, French, Lars, Dummer, Reinhard and Marghoob, Ashfaq A. (2017). Electrical Impedance Spectroscopy in Skin Cancer Diagnosis. Dermatologic Clinics, 35 (4), 489-+. doi: 10.1016/j.det.2017.06.009 |
|
2017 Conference Publication Immunotherapy in patients with concurrent solid organ transplant, HIV, and Hepatitis B and CRai, R., Ezeoke, O. M., McQuade, J. L., Zimmer, L., Koo, C., Park, J. J., Ardolino, L., Yip, D., Goldinger, S., Cohen, J. V., Millward, M., Atkinson, V., Kane, A. Y., Ascierto, P. A., Garbe, C., Gutzmer, R., Johnson, D. B., Hellman, M. D., Long, G. V. and Menzies, A. M. (2017). Immunotherapy in patients with concurrent solid organ transplant, HIV, and Hepatitis B and C. 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid Spain, Sep 08-12, 2017. OXFORD: OXFORD UNIV PRESS. |
|
2017 Conference Publication Melanoma patients treated with Encorafenib show less hyperproliferative keratinocytic cutaneous adverse events and more intense inflammatory palmoplantar erythrodysesthesia compared to other BRAF inhibitorsGraf, N., Goldinger, S., Galliker, N., Conrad, S. and Dummer, R. (2017). Melanoma patients treated with Encorafenib show less hyperproliferative keratinocytic cutaneous adverse events and more intense inflammatory palmoplantar erythrodysesthesia compared to other BRAF inhibitors. HOBOKEN: WILEY. |
|
2017 Journal Article Interstitial granulomatous dermatitis during talimogen laherparepvec treatmentFrauchiger, Anna L., Bruggen, Marie-Charlotte, Goldinger, Simone M. and Dummer, Reinhard (2017). Interstitial granulomatous dermatitis during talimogen laherparepvec treatment. Melanoma Research, 27 (4), 400-401. doi: 10.1097/CMR.0000000000000369 |
|
2017 Journal Article Successful treatment with imatinib after nilotinib and ipilimumab in a c-kit-mutated advanced melanoma patient: a case reportMurer, Carla, Kranzlin-Stieger, Pascale, French, Lars E., Dummer, Reinhard and Goldinger, Simone M. (2017). Successful treatment with imatinib after nilotinib and ipilimumab in a c-kit-mutated advanced melanoma patient: a case report. Melanoma Research, 27 (4), 396-398. doi: 10.1097/CMR.0000000000000358 |
|
2017 Journal Article Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in SwitzerlandMangana, Joanna, Cheng, Phil F., Kaufmann, Corina, Amann, Valerie C., Frauchiger, Anna L., Stoegner, Viola, Held, Ulrike, von Moos, Roger, Michielin, Olivier, Braun, Ralph P., Levesque, Mitchell P., Goldinger, Simone M. and Dummer, Reinhard (2017). Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland. Melanoma Research, 27 (4), 358-368. doi: 10.1097/CMR.0000000000000359 |
|
2017 Journal Article A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation statusIzar, Benjamin, Sharfman, William, Hodi, F. Stephen, Lawrence, Donald, Flaherty, Keith T., Amaravadi, Ravi, Kim, Kevin B., Puzanov, Igor, Sosman, Jeffrey, Dummer, Reinhard, Goldinger, Simone M., Lam, Lyhping, Kakar, Shefali, Tang, Zhongwen, Krieter, Oliver, McDermott, David F. and Atkins, Michael B. (2017). A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status. Cancer Medicine, 6 (8), 1904-1914. doi: 10.1002/cam4.1140 |
